{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:10:06Z","timestamp":1756285806975,"version":"3.44.0"},"reference-count":28,"publisher":"BMJ","issue":"4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["DTB"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1136\/dtb.2022.241203rep","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T12:55:18Z","timestamp":1661432118000},"page":"61-63","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Denosumab and bisphosphonate associated bilateral osteonecrosis of the external auditory canal"],"prefix":"10.1136","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0931-7517","authenticated-orcid":false,"given":"Harry David","family":"True","sequence":"first","affiliation":[{"name":"University of Exeter Medical School, Exeter, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupert George","family":"Ricks","sequence":"additional","affiliation":[{"name":"Ear, Nose and Throat (ENT) Department, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel Anthony","family":"Smith","sequence":"additional","affiliation":[{"name":"Ear, Nose and Throat (ENT) Department, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"key":"2025082701342941000_61.4.61.1","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-017-0324-5"},{"key":"2025082701342941000_61.4.61.2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2405"},{"key":"2025082701342941000_61.4.61.3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1017\/S0022215118000324","article-title":"Bisphosphonate-Induced osteonecrosis of the ear canal: our experience and a review of the literature","volume":"132","author":"McCadden","year":"2018","journal-title":"J Laryngol Otol"},{"key":"2025082701342941000_61.4.61.4","first-page":"107","article-title":"Bisphosphonate-Associated ear canal osteonecrosis: a case report and review of the literature","volume":"2","author":"Takahashi","year":"2017","journal-title":"Acta Otolaryngol Case Rep"},{"key":"2025082701342941000_61.4.61.5","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00198-018-4791-3","article-title":"A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk","volume":"30","author":"Nayak","year":"2019","journal-title":"Osteoporos Int"},{"key":"2025082701342941000_61.4.61.6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012432.pub2"},{"key":"2025082701342941000_61.4.61.7","unstructured":"Denosumab for the prevention of osteoporotic fractures in postmenopausal women, 2010. Available: https:\/\/www.nice.org.uk\/guidance\/ta204\/chapter\/1-Guidance [Accessed 5 Jul 2020]."},{"key":"2025082701342941000_61.4.61.8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jpainsymman.2018.05.021","article-title":"Denosumab","volume":"56","author":"Wilcock","year":"2018","journal-title":"J Pain Symptom Manage"},{"key":"2025082701342941000_61.4.61.9","unstructured":"Denosumab (Prolia, Xgeva): Reports of Osteonecrosis of the External Auditory Canal, 2017. Available: https:\/\/www.gov.uk\/drug-safety-update\/denosumab-prolia-xgeva-reports-of-osteonecrosis-of-the-external-auditory-canal [Accessed 24 Jun 2020]."},{"key":"2025082701342941000_61.4.61.10","first-page":"30163","article-title":"Denosumab-induced osteonecrosis of external auditory canal","volume":"S0385-8146","author":"Takeda","year":"2020","journal-title":"Auris Nasus Larynx"},{"key":"2025082701342941000_61.4.61.11","doi-asserted-by":"publisher","DOI":"10.1007\/s12105-018-0915-5"},{"key":"2025082701342941000_61.4.61.12","doi-asserted-by":"publisher","DOI":"10.1080\/00016489.2017.1295468"},{"key":"2025082701342941000_61.4.61.13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s12105-018-0908-4","article-title":"Squamous cell carcinoma of the external auditory canal and temporal bone: an update","volume":"12","author":"Allanson","year":"2018","journal-title":"Head Neck Pathol"},{"key":"2025082701342941000_61.4.61.14","first-page":"2811","article-title":"Differences between bisphosphonate-related and denosumab-related osteonecrosis of the jaws: a systematic review","volume":"29","author":"Querrer","year":"2021","journal-title":"Support Care Cancer"},{"key":"2025082701342941000_61.4.61.15","unstructured":"Ear infections, antibacterial therapy | treatment summary | BNF content published by NICE. Available: https:\/\/bnf.nice.org.uk\/treatment-summary\/ear-infections-antibacterial-therapy.html [Accessed 21 Mar 2021]."},{"key":"2025082701342941000_61.4.61.16","unstructured":"Cholesteatoma - Symptoms, diagnosis and treatment | BMJ Best Practice. Available: https:\/\/bestpractice.bmj.com\/topics\/en-gb\/1033\/treatment-algorithm [Accessed 21 Mar 2021]."},{"key":"2025082701342941000_61.4.61.17","unstructured":"Bisphosphonates: very rare reports of osteonecrosis of the external auditory canal, 2015. Available: https:\/\/www.gov.uk\/drug-safety-update\/bisphosphonates-very-rare-reports-of-osteonecrosis-of-the-external-auditory-canal [Accessed 23 Jun 2020]."},{"key":"2025082701342941000_61.4.61.18","unstructured":"Denosumab | drug | BNF content published by NICE. Available: https:\/\/bnf.nice.org.uk\/drug\/denosumab.html#sideEffects [Accessed 21 Mar 2021]."},{"key":"2025082701342941000_61.4.61.19","unstructured":"UK Chemotherapy Board . Medication-Related osteonecrosis of the jaw. guidance for the oncology multidisciplinary team. Report of a working Party on behalf of the UK chemotherapy board. UKCB, 2019."},{"key":"2025082701342941000_61.4.61.20","doi-asserted-by":"crossref","DOI":"10.1007\/s40278-017-32659-2","article-title":"Denosumab-linked osteonecrosis of external auditory canal","volume":"1659","year":"2017","journal-title":"Reactions Weekly"},{"key":"2025082701342941000_61.4.61.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05833.x"},{"key":"2025082701342941000_61.4.61.22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00405-011-1496-z","article-title":"Bisphosphonate-Induced osteonecrosis of the external ear canal: a retrospective study","volume":"268","author":"Froelich","year":"2011","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2025082701342941000_61.4.61.23","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00106-012-2554-6","article-title":"Beidseitige bisphosphonatassoziierte Osteonekrose des Geh\u00f6rgangs","volume":"60","author":"Bast","year":"2012","journal-title":"HNO"},{"key":"2025082701342941000_61.4.61.24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000353214","article-title":"Surgical management of benign idiopathic osteonecrosis of the external auditory canal","volume":"75","author":"Saxby","year":"2013","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"2025082701342941000_61.4.61.25","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1017\/S002221511300100X","article-title":"Bisphosphonate-Associated osteonecrosis of the external auditory canal","volume":"127 Suppl 2","author":"Wickham","year":"2013","journal-title":"J Laryngol Otol"},{"key":"2025082701342941000_61.4.61.26","first-page":"3","article-title":"Bisphosphonate-Induced osteonecrosis of the external auditory canal: a case report","volume":"2","author":"Thorsteinsson","year":"2015","journal-title":"J Clin Med Case Reports"},{"key":"2025082701342941000_61.4.61.27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/MAO.0b013e31827ca34d","article-title":"Osteonecrosis of the external auditory canal associated with oral bisphosphonate therapy: case report and literature review","volume":"34","author":"Salzman","year":"2013","journal-title":"Otol Neurotol"},{"key":"2025082701342941000_61.4.61.28","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.bjoms.2013.02.013","article-title":"Bisphosphonate-Associated osteonecrosis of the auditory canal","volume":"51","author":"Kharazmi","year":"2013","journal-title":"Br J Oral Maxillofac Surg"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.2022.241203rep","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:34:40Z","timestamp":1756283680000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.2022.241203rep"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,3,29]]},"published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10.1136\/dtb.2022.241203rep"],"URL":"https:\/\/doi.org\/10.1136\/dtb.2022.241203rep","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[2022,8,25]]}}}